Free Trial

SG Americas Securities LLC Invests $1.05 Million in Addus HomeCare Corporation (NASDAQ:ADUS)

Addus HomeCare logo with Medical background

SG Americas Securities LLC acquired a new position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 10,621 shares of the company's stock, valued at approximately $1,050,000. SG Americas Securities LLC owned 0.06% of Addus HomeCare as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in ADUS. Capital Research Global Investors bought a new position in shares of Addus HomeCare in the 4th quarter worth approximately $51,149,000. American Century Companies Inc. lifted its stake in shares of Addus HomeCare by 695.8% in the 4th quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock worth $35,643,000 after purchasing an additional 248,613 shares during the period. GAMMA Investing LLC lifted its stake in shares of Addus HomeCare by 10,307.8% in the 1st quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock worth $12,948,000 after purchasing an additional 129,672 shares during the period. Bank of America Corp DE lifted its stake in shares of Addus HomeCare by 273.6% in the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock worth $21,945,000 after purchasing an additional 128,211 shares during the period. Finally, TimesSquare Capital Management LLC lifted its stake in shares of Addus HomeCare by 28.5% in the 4th quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock worth $44,593,000 after purchasing an additional 78,835 shares during the period. Institutional investors own 95.35% of the company's stock.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of Addus HomeCare stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the completion of the transaction, the executive vice president now directly owns 7,796 shares of the company's stock, valued at $896,540. The trade was a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.60% of the stock is owned by insiders.

Wall Street Analyst Weigh In

ADUS has been the topic of a number of recent analyst reports. Wall Street Zen cut shares of Addus HomeCare from a "buy" rating to a "hold" rating in a research note on Wednesday, February 26th. Stephens reaffirmed an "overweight" rating and set a $142.00 price objective on shares of Addus HomeCare in a report on Wednesday, March 12th. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a report on Friday. Finally, Macquarie reaffirmed an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of "Buy" and an average price target of $142.57.

Get Our Latest Report on ADUS

Addus HomeCare Price Performance

Shares of ADUS stock traded down $1.37 on Friday, reaching $113.79. The company's stock had a trading volume of 195,824 shares, compared to its average volume of 170,652. The stock's fifty day simple moving average is $108.91 and its 200-day simple moving average is $111.98. Addus HomeCare Corporation has a 1 year low of $88.96 and a 1 year high of $136.72. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.20. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of 25.69, a price-to-earnings-growth ratio of 1.63 and a beta of 0.81.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. The company had revenue of $337.71 million during the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. Addus HomeCare's quarterly revenue was up 20.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.21 earnings per share. Analysts forecast that Addus HomeCare Corporation will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Further Reading

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Bought This Stock at the Bottom—Will You Miss It?
The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines